NO180678C - N-substituerte heterocykliske forbindelser og farmasöytisk preparat - Google Patents
N-substituerte heterocykliske forbindelser og farmasöytisk preparatInfo
- Publication number
- NO180678C NO180678C NO923509A NO923509A NO180678C NO 180678 C NO180678 C NO 180678C NO 923509 A NO923509 A NO 923509A NO 923509 A NO923509 A NO 923509A NO 180678 C NO180678 C NO 180678C
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparation
- substituted heterocyclic
- heterocyclic compounds
- compounds
- substituted
- Prior art date
Links
- 150000001421 N-substituted heterocyclic compounds Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9111161A FR2681067B1 (fr) | 1991-09-10 | 1991-09-10 | Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO923509D0 NO923509D0 (no) | 1992-09-09 |
| NO923509L NO923509L (no) | 1993-03-11 |
| NO180678B NO180678B (no) | 1997-02-17 |
| NO180678C true NO180678C (no) | 1997-05-28 |
Family
ID=9416798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO923509A NO180678C (no) | 1991-09-10 | 1992-09-09 | N-substituerte heterocykliske forbindelser og farmasöytisk preparat |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0532410A1 (enExample) |
| JP (1) | JPH05213894A (enExample) |
| KR (1) | KR930006008A (enExample) |
| AU (1) | AU661017B2 (enExample) |
| CA (1) | CA2077967A1 (enExample) |
| CZ (1) | CZ275992A3 (enExample) |
| FR (1) | FR2681067B1 (enExample) |
| HU (1) | HUT63616A (enExample) |
| IL (1) | IL103116A (enExample) |
| LT (1) | LT3148B (enExample) |
| LV (1) | LV10255B (enExample) |
| MX (1) | MX9205155A (enExample) |
| MY (1) | MY108089A (enExample) |
| NO (1) | NO180678C (enExample) |
| NZ (1) | NZ244258A (enExample) |
| PL (1) | PL171524B1 (enExample) |
| RU (1) | RU2107062C1 (enExample) |
| TW (1) | TW218871B (enExample) |
| ZA (1) | ZA926899B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69131021T2 (de) * | 1990-12-14 | 1999-08-12 | Smithkline Beecham Corp., Philadelphia, Pa. 19101 | Angiotensin-ii-rezeptor blockierende zusammensetzungen |
| US5484939A (en) * | 1993-03-12 | 1996-01-16 | Lonza Ltd. | 2-substituted 5-chlorimidazoles |
| US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
| HU218681B (hu) * | 1997-07-25 | 2000-10-30 | Sanofi-Synthelabo | Eljárás 1,3-diaza-spiro(4,4)non-1-én-4-on-származékok előállitására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek |
| HU218680B (hu) | 1997-07-25 | 2000-10-30 | Sanofi-Synthelabo | Eljárás 1,3-diaza-spiro[4,4]non-1-én-4-on-származékok előállítására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek |
| IL140622A0 (en) | 1998-07-06 | 2002-02-10 | Bristol Myers Squibb Co | Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof |
| US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| DE19832428A1 (de) * | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) * | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US7091232B2 (en) * | 2002-05-21 | 2006-08-15 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| AU2004208615C1 (en) | 2003-01-31 | 2010-05-13 | Daiichi Sankyo Company, Limited | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| EP1750862B1 (en) | 2004-06-04 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing irbesartan |
| BRPI0609879A2 (pt) * | 2005-04-28 | 2010-05-11 | Pfizer Ltd | derivados de aminoácidos |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| HK1220696A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 鸟苷酸环化酶激动剂及其用途 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| EP4424697A3 (en) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH539640A (de) | 1970-05-29 | 1973-07-31 | Agripat Sa | Verfahren zur Herstellung neuer, herbizid wirksamer s-Triazine und deren Verwendung zur Bekämpfung von Unkräutern |
| US4017510A (en) | 1975-11-12 | 1977-04-12 | American Cyanamid Company | Imidazoisoindolediones and the use thereof as herbicidal agents |
| DE3545597A1 (de) * | 1985-12-21 | 1987-07-02 | Celamerck Gmbh & Co Kg | Neue herbizid wirksame imidazolinone |
| EP0303863A3 (en) * | 1987-08-17 | 1991-10-23 | American Cyanamid Company | Benzenesulfonyl carboxamide compounds, intermediate compounds and methods of preparation thereof and use of said compounds and intermediate compounds as herbicidal agents |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| CA2020073A1 (en) * | 1989-07-03 | 1991-01-04 | Eric E. Allen | Substituted quinazolinones as angiotensin ii antagonists |
| DE69024556T2 (de) * | 1989-07-28 | 1996-10-17 | Merck & Co Inc | Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten |
| IL99372A0 (en) * | 1990-09-10 | 1992-08-18 | Ciba Geigy Ag | Azacyclic compounds |
| JP2004247578A (ja) | 2003-02-14 | 2004-09-02 | Kawasaki Microelectronics Kk | 半導体装置および半導体装置の製造方法 |
-
1991
- 1991-09-10 FR FR9111161A patent/FR2681067B1/fr not_active Expired - Fee Related
-
1992
- 1992-08-26 TW TW081106738A patent/TW218871B/zh active
- 1992-09-04 MY MYPI92001566A patent/MY108089A/en unknown
- 1992-09-04 LV LVP-92-109A patent/LV10255B/xx unknown
- 1992-09-04 CZ CS922759A patent/CZ275992A3/cs unknown
- 1992-09-08 NZ NZ244258A patent/NZ244258A/en unknown
- 1992-09-08 LT LTIP119A patent/LT3148B/lt not_active IP Right Cessation
- 1992-09-09 NO NO923509A patent/NO180678C/no unknown
- 1992-09-09 MX MX9205155A patent/MX9205155A/es unknown
- 1992-09-09 IL IL103116A patent/IL103116A/en not_active IP Right Cessation
- 1992-09-09 RU SU5052773A patent/RU2107062C1/ru active
- 1992-09-09 HU HU9202889A patent/HUT63616A/hu unknown
- 1992-09-09 KR KR1019920016618A patent/KR930006008A/ko not_active Ceased
- 1992-09-09 EP EP92402459A patent/EP0532410A1/fr not_active Withdrawn
- 1992-09-09 PL PL92295874A patent/PL171524B1/pl unknown
- 1992-09-10 JP JP4242126A patent/JPH05213894A/ja not_active Withdrawn
- 1992-09-10 AU AU22868/92A patent/AU661017B2/en not_active Ceased
- 1992-09-10 CA CA002077967A patent/CA2077967A1/en not_active Abandoned
- 1992-09-10 ZA ZA926899A patent/ZA926899B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9205155A (es) | 1993-03-01 |
| TW218871B (enExample) | 1994-01-11 |
| HU9202889D0 (en) | 1992-11-30 |
| IL103116A0 (en) | 1993-02-21 |
| AU661017B2 (en) | 1995-07-13 |
| NO923509D0 (no) | 1992-09-09 |
| CA2077967A1 (en) | 1993-03-11 |
| HUT63616A (en) | 1993-09-28 |
| LV10255A (lv) | 1994-10-20 |
| LTIP119A (en) | 1994-07-15 |
| LV10255B (en) | 1995-04-20 |
| NZ244258A (en) | 1996-10-28 |
| FR2681067A1 (fr) | 1993-03-12 |
| PL171524B1 (pl) | 1997-05-30 |
| MY108089A (en) | 1996-08-15 |
| NO180678B (no) | 1997-02-17 |
| NO923509L (no) | 1993-03-11 |
| RU2107062C1 (ru) | 1998-03-20 |
| FR2681067B1 (fr) | 1993-12-17 |
| KR930006008A (ko) | 1993-04-20 |
| IL103116A (en) | 1998-04-05 |
| JPH05213894A (ja) | 1993-08-24 |
| LT3148B (en) | 1995-01-31 |
| CZ275992A3 (en) | 1993-03-17 |
| ZA926899B (en) | 1993-03-16 |
| AU2286892A (en) | 1993-03-11 |
| EP0532410A1 (fr) | 1993-03-17 |
| PL295874A1 (en) | 1993-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO180678C (no) | N-substituerte heterocykliske forbindelser og farmasöytisk preparat | |
| NO924768L (no) | Farmasoeytisk preparat og fremgangsmaate for dets fremstilling | |
| NO921451D0 (no) | Heterocykliske amider | |
| DK1023900T3 (da) | Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf | |
| NO922506L (no) | Farmasoeytiske preparat | |
| NO954239D0 (no) | Heterocykliske forbindelser og deres fremstilling og anvendelse | |
| NO921958D0 (no) | Farmasoeytisk preparat | |
| NO922006D0 (no) | Farmasoeytisk preparat | |
| DE69224656D1 (de) | Arzneimittel | |
| DK0720609T3 (da) | 3-(5-Tetrazolylbenzyl)aminoperidinderivater og antagonister for tachykininer | |
| NO307707B1 (no) | Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav | |
| FI922481A7 (fi) | Heterosyklisiä johdannaisia | |
| NO921012L (no) | Farmasoeytiske preparater og deres anvendelse | |
| FI953666A7 (fi) | Hetersykliset yhdisteet ja niiden valmistus ja käyttö | |
| NO961274D0 (no) | Azolderivat og farmasöytiske preparat derav | |
| NO308533B1 (no) | Heteroarylaminer, anvendelse derav og farmasøytisk preparat | |
| BR9200058A (pt) | Composto e composicao farmaceutica | |
| FI945052A7 (fi) | Anti-iskeeminen lääke | |
| DK162491D0 (da) | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne | |
| NO934372D0 (no) | Nye forbindelser og farmas!ytisk preparat derav | |
| NO304890B1 (no) | Farmas°ytiske forbindelser og farmas°ytiske preparater | |
| NO930796D0 (no) | Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse | |
| DK522888D0 (da) | Heterocykliske derivater og farmaceutiske praeparater med indhold af saadanne | |
| NO903386D0 (no) | Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-karbamater og -tiokarbamater og derivater derav. | |
| FI923869L (fi) | Farmaceutiska aemnen |